Brief: Arrowhead Pharmaceuticals Expects $200 Million Milestone By End Of 2025
28/07/2025 12:46
July 28 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O: ARROWHEAD PHARMACEUTICALS EARNS $100 MILLION MILESTONE FROM SAREPTA THERAPEUTICS ARROWHEAD PHARMACEUTICALS INC - EXPECTS $200 MILLION MILESTONE BY END OF 2025 Source text: ID:nBwrlWZna Further company coverage: ARWR.O (Reporting by Anshi Sancheti) ((Anshi.Sancheti@thomsonreuters.com;))
Recent news on Arrowhead Pharmaceuticals
See all newsBrief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers